Skip to content

Comparison of the effect of lavandula and citrus aurantium on depression and sleep quality in menopausal women

Comparison of the effect of lavandula and citrus aurantium on depression and sleep quality in menopausal women

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201504236582N11
Enrollment
156
Registered
2015-10-09
Start date
2015-07-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: sleep quality. Condition 2: depression. Menopausal and female climacteric states Depressive episode

Interventions

Intervention 1: The citrus aurantium group will receive capsules containing 500 mg Citrus aurantium flower’s Powder twice a day after breakfast and dinner for 8 weeks. Intervention 2: The lavender gro
Treatment - Drugs
The citrus aurantium group will receive capsules containing 500 mg Citrus aurantium flower’s Powder twice a day after breakfast and dinner for 8 weeks.
The lavender group will receive capsules containing 500 mg of Lavender flower’s Powdertwice a day after breakfast and dinner for 8 weeks.
The control group will receive capsules containing 500 mg starchtwice a day after breakfast and dinner for 8 weeks.

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
45 Years to 60 Years

Inclusion criteria

Inclusion criteria: The inclusion criteria: 45-60 years old; 1 to 6 years after the last menstrual period which start by natural menopause; getting more than 5 score from Pittsburgh Sleep Quality Index (PSQI);getting between4-28 score from Beck depression score; not taking hypnotic and anti depressant drugs; not taking tobacco and alcohol; having phone number for follow-up; without history of asthma and allergy to specific plants or citrus; Lack of acute gastrointestinal problems declared by herself; Living in Urmia; the desire to participate in the study Exclusion Criteria: Having travel or home change during intervention; Having a history of severe physical and mental disease that causes sleep disorders and depression; Death of a relative in the past three months, encounter with the events that caused sleep disorders and depression; Regular weekly or professional exercise; The use of other methods of traditional medicine

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Sleep quality. Timepoint: before and 8 week after intervention. Method of measurement: Pittsburgh Sleep Quality Index.;Depression. Timepoint: before and 8 week after intervention. Method of measurement: Beck Depression Questionnaire.

Secondary

MeasureTime frame
Satisfaction of postmenopausal women. Timepoint: 8 weeks after intervention. Method of measurement: Checklist.;Anxiety. Timepoint: Before and 8 weeks after intervention. Method of measurement: (STAI) questionnaire.;Adverse events. Timepoint: 8 weeks after intervention. Method of measurement: Checklist.;Personal and social characteristics associated with depression and sleep quality scores in the groups studied. Timepoint: Before intervention. Method of measurement: Demographic questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahin Kamalifard

Nursing and Midwifery, Tabriz University of Medical Sciences

kamalifardm@tbzmed.ac.ir+98 34796770

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026